Bone Biologics (BBLG) Amortizatization of Intangibles (2014 - 2018)
Bone Biologics (BBLG) posted quarterly Amortizatization of Intangibles of $26990.0 for Q3 2018, down 82.21% year-over-year from $151680.0 in Q3 2017, and down 82.79% quarter-over-quarter from $156872.0 in Q2 2018.
Powered by 
Analysis
Bone Biologics (BBLG) Amortizatization of Intangibles (2014 - 2018) Analysis & Trends
Bone Biologics (BBLG) has reported Amortizatization of Intangibles for 5 consecutive years, with $26990.0 the latest figure, recorded in Q3 2018.
- In Q3 2018, Amortizatization of Intangibles fell 82.21% year-over-year to $26990.0; the TTM figure through Dec 2019 stood at $26990.0 (down 92.08% YoY), while the FY2018 annual figure was $340735.0, down 89.76% from the prior year.
- Amortizatization of Intangibles slipped to $26990.0 in Q3 2018 per BBLG's latest filing, from $156872.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.4 million in Q4 2016 and bottomed at -$2.6 million in Q2 2015.
- Historically, Amortizatization of Intangibles has averaged $59205.9 across 5 years, with a median of $135611.0 in 2015.
- Annual changes were most pronounced in 2015 — Amortizatization of Intangibles plunged 6072.13% — and 2016, when it soared 680.29%.
- Bone Biologics' Amortizatization of Intangibles stood at $73572.0 in 2014, then surged by 136.36% to $173892.0 in 2015, then jumped by 680.29% to $1.4 million in 2016, then slipped by 13.85% to $1.2 million in 2017, then plunged by 97.69% to $26990.0 in 2018.
- Business Quant data shows BBLG's Amortizatization of Intangibles at $26990.0 in Q3 2018, $156872.0 in Q2 2018, and $156873.0 in Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 678,000.00 |
| 10 | Bone Biologics | 1.00 Mn | 1.00 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 26,990.00 |
| Jun 30, 2018 | 156,872.00 |
| Mar 31, 2018 | 156,873.00 |
| Dec 31, 2017 | 1.17 Mn |
| Sep 30, 2017 | -1.01 Mn |
| Jun 30, 2017 | 859,521.00 |
| Mar 31, 2017 | 520,508.00 |
| Dec 31, 2016 | 1.36 Mn |
| Sep 30, 2016 | -404,480.00 |
| Jun 30, 2016 | 252,800.00 |
| Mar 31, 2016 | 117,726.00 |
| Dec 31, 2015 | 173,892.00 |
| Sep 30, 2015 | 173,892.00 |
| Jun 30, 2015 | -2.62 Mn |
| Mar 31, 2015 | 119,542.00 |
| Dec 31, 2014 | 73,572.00 |
| Jun 30, 2014 | 43,805.00 |
| Mar 31, 2014 | 47,306.00 |